This is a preview of subscription content, access via your institution
Relevant articles
Open Access articles citing this article.
-
Interstitial lung diseases after hematopoietic stem cell transplantation: New pattern of lung chronic graft-versus-host disease?
Bone Marrow Transplantation Open Access 29 October 2022
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Bergeron A, Chevret S, Peffault de Latour R, Chagnon K, de Margerie-Mellon C, Rivière F, et al. Noninfectious lung complications after allogeneic haematopoietic stem cell transplantation. Eur Respir J. 2018;51:1702617
Schlemmer F, Chevret S, Lorillon G, De Bazelaire C, Peffault de Latour R, Meignin V, et al. Late-onset noninfectious interstitial lung disease after allogeneic hematopoietic stem cell transplantation. Respir Med. 2014;108:1525–33.
Meignin V, Thivolet-Bejui F, Kambouchner M, Hussenet C, Bondeelle L, Mitchell A, et al. Lung histopathology of noninfectious pulmonary complications after allogeneic hematopoietic stem cell transplantation. Histopathology. 2018;73:832–42.
von der Thüsen JH, Hansell DM, Tominaga M, Veys PA, Ashworth MT, Owens CM, et al. Pleuroparenchymal fibroelastosis in patients with pulmonary disease secondary to bone marrow transplantation. Mod Pathol. 2011;24:1633–9.
Okimoto T, Tsubata Y, Hamaguchi M, Sutani A, Hamaguchi S, Isobe T. Pleuroparenchymal fibroelastosis after haematopoietic stem cell transplantation without graft-versus-host disease findings. Respirol Case Rep. 2018;6:e00298.
Matsui T, Maeda T, Kida T, Fujita J, Tsuji H, Morii E, et al. Pleuroparenchymal fibroelastosis after allogenic hematopoietic stem cell transplantation: important histological component of late-onset noninfectious pulmonary complication accompanied with recurrent pneumothorax. Int J Hematol. 2016;104:525–30.
Takeuchi Y, Miyagawa-Hayashino A, Chen F, Kubo T, Handa T, Date H, et al. Pleuroparenchymal fibroelastosis and non-specific interstitial pneumonia: frequent pulmonary sequelae of haematopoietic stem cell transplantation. Histopathology. 2015;66:536–44.
Namkoong H, Ishii M, Mori T, Sugiura H, Tasaka S, Sakurai M, et al. Clinical and radiological characteristics of patients with late-onset severe restrictive lung defect after hematopoietic stem cell transplantation. BMC Pulm Med. 2017;17:123.
Mariani F, Gatti B, Rocca A, Bonifazi F, Cavazza A, Fanti S, et al. Pleuroparenchymal fibroelastosis: the prevalence of secondary forms in hematopoietic stem cell and lung transplantation recipients. Diagn Interv Radiol. 2016;22:400–6.
Enomoto Y, Nakamura Y, Satake Y, Sumikawa H, Johkoh T, Colby TV, et al. Clinical diagnosis of idiopathic pleuroparenchymal fibroelastosis: a retrospective multicenter study. Respir Med. 2017;133:1–5.
Reddy TL, Tominaga M, Hansell DM, Von Der Thusen J, Rassl D, Parfrey H, et al. Pleuroparenchymal fibroelastosis: a spectrum of histopathological and imaging phenotypes. Eur Respir J. 2012;40:377–85.
Travis WD, Costabel U, Hansell DM, King TE, Lynch DA, Nicholson AG, et al. An official American Thoracic Society/European Respiratory Society statement: Update of the international multidisciplinary classification of the idiopathic interstitial pneumonias. Am J Respir Crit Care Med. 2013;188:733–48.
Yang J-Y, Oh SY, Song JW, Shim TS, Lee SW, Lee JS, et al. Restrictive chronic lung function decline after haematopoietic stem cell transplantation. Eur Respir J. 2016;47:336–9.
Ofek E, Sato M, Saito T, Wagnetz U, Roberts HC, Chaparro C, et al. Restrictive allograft syndrome post lung transplantation is characterized by pleuroparenchymal fibroelastosis. Mod Pathol. 2013;26:350–6.
Ishii T, Bandoh S, Kanaji N, Tadokoro A, Watanabe N, Imataki O, et al. Air-leak syndrome by pleuroparenchymal fibroelastosis after bone marrow transplantation. Intern Med. 2016;55:105–11.
Vos R, Verleden SE, Ruttens D, Vandermeulen E, Yserbyt J, Dupont LJ, et al. Pirfenidone: a potential new therapy for restrictive allograft syndrome? Am J Transplant. 2013;13:3035–40.
Sato S, Hanibuchi M, Takahashi M, Fukuda Y, Morizumi S, Toyoda Y, et al. A patient with idiopathic pleuroparenchymal fibroelastosis showing a sustained pulmonary function due to treatment with pirfenidone. Intern Med. 2016;55:497–501.
Vos R, Wuyts WA, Gheysens O, Goffin KE, Schaevers V, Verleden SE, et al. Pirfenidone in restrictive allograft syndrome after lung transplantation: a case series. Am J Transplant. 2018;18:3045–59.
Shimada A, Terada J, Tsushima K, Tateishi Y, Abe R, Oda S, et al. Veno-venous extracorporeal membrane oxygenation bridged living-donor lung transplantation for rapid progressive respiratory failure with pleuroparenchymal fibroelastosis after allogeneic hematopoietic stem cell transplantation. Respir Investig. 2018;56:258–62.
Bonifazi M, Montero MA, Renzoni EA. Idiopathic pleuroparenchymal fibroelastosis. Curr Pulmonol Rep. 2017;6:9–15.
Greer M, Berastegui C, Jaksch P, Benden C, Aubert J, Roux A, et al. Lung transplantation after allogeneic stem cell transplantation: a pan-European experience. Eur Respir J. 2018;51:1701330.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that they have no conflict of interest.
Additional information
Publisher’s note: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Supplementary information
Rights and permissions
About this article
Cite this article
Bondeelle, L., Gras, J., Michonneau, D. et al. Pleuroparenchymal fibroelastosis after allogeneic hematopoietic stem cell transplantation. Bone Marrow Transplant 55, 982–986 (2020). https://doi.org/10.1038/s41409-019-0636-8
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/s41409-019-0636-8
This article is cited by
-
Interstitial lung diseases after hematopoietic stem cell transplantation: New pattern of lung chronic graft-versus-host disease?
Bone Marrow Transplantation (2023)
-
Pleuroparenchymal Fibroelastosis (PPFE) — An Update
Current Pulmonology Reports (2023)
-
Pleuroparenchymal fibroelastosis after hematopoietic stem cell transplantation in children: a propensity score–matched analysis
European Radiology (2022)